MPT: Cell Therapy Disappoints in PAD Patients

ACC Conference Reporter

AHA 2017 | ANAHEIM — Given alone or in combination with exercise, granulocyte-macrophage colony-stimulating factor (GM-CSF) injections didn't improve walking performance in patients with lower-extremity peripheral artery disease (PAD), results from the PROPEL randomized trial suggested. Read More >>>

Keywords: AHA Annual Scientific Sessions, AHA17

< Back to Listings